Skip to content

Use of Pedometer Following Radical Cystectomy

Does the Use of a Post-Operative Pedometer Affect Rate of Return of Bowel Function and Narcotic Use Following Radical Cystectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04305730
Enrollment
35
Registered
2020-03-12
Start date
2021-03-31
Completion date
2021-05-31
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Ileus, Narcotic Use

Keywords

radical cystectomy, narcotic use, post-operative ileus, return of bowel function

Brief summary

This is a study to evaluate whether use of a pedometer following radical cystectomy decreases post-operative narcotic use and time to return of bowel function.

Detailed description

This is a randomized controlled prospective study looking at the effect of using a pedometer with graduated step-count goals following radical cystectomy on rate of ileus, return of bowel function and post-operative narcotic use. Subjects will be randomized into a control group or study group. The control group will receive standard of care, with information provided regarding the importance of ambulation following surgery. The study group will receive a pedometer with graduated step-count goals from post-operative day 0 to post-operative day 21. Both groups will be given a standardized post-operative narcotic regimen, and will be asked to record initial passage of flatus and first bowel movement. Subjects will remain on the study until post-operative day 21.

Interventions

Subjects in the study group will receive a pedometer with graduated step count goals as discussed in arm description.

BEHAVIORALStandard of care

Subjects in the control group will be counseled on the importance of ambulation during their pre-operative visit.

Sponsors

Virginia Mason Hospital/Medical Center
CollaboratorOTHER
Benaroya Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

This study will include men and women age18-75 undergoing radical cystectomy for bladder cancer at Virginia Mason Medical Center. This includes both open and robot-assisted radical cystectomy, and all types of urinary diversion will be included in the trial. Subjects both with and without neo-adjuvant chemotherapy will be included in the study.

Exclusion criteria

* Long-term opioid use, defined by CDC as use of opioids on most days for \>3 months * History of inflammatory bowel disease * Prior abdominopelvic radiation * Travel to Europe during study period * Concurrent surgery during radical cystectomy * Inability to ambulate * Gastroparesis or other baseline bowel dysmotility issues * Inability or unwillingness of subject or legal guardian/representative to give written informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Rate of post-operative ileus7-21 daysStandard definition
Rate of return of bowel function5-15 daysFirst passage of flatus/stool

Secondary

MeasureTime frameDescription
Post-operative narcotic use7-21 daysMorphine equivalents used following radical cystectomy.
Hospital length of stay3-14 daysTime begins day of surgery to day of discharge. Time in days
Post-operative pain scores1-21 daysNumerical Rating Scale Pain Scores (Range: 0-10, where 0 is no pain and 10 is the worst pain)
Length of time under general anesthesia180-420 minutesTime from induction to emergence of anesthesia in minutes

Countries

United States

Contacts

Primary ContactBasil Ferenczi, MD
basil.ferenczi@virginiamason.org206-223-6600

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026